Mackay Shields LLC’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-72,688
Closed -$990K 1591
2020
Q2
$990K Buy
72,688
+14,100
+24% +$194K 0.01% 1021
2020
Q1
$762K Buy
58,588
+12,800
+28% +$228K 0.01% 1031
2019
Q4
$923K Sell
45,788
-5,700
-11% -$138K 0.01% 1085
2019
Q3
$1.32M Sell
51,488
-13,000
-20% -$319K 0.01% 1046
2019
Q2
$1.57M Buy
64,488
+37,206
+136% +$813K 0.01% 996
2019
Q1
$544K Sell
27,282
-700
-3% -$12.8K ﹤0.01% 1156
2018
Q4
$461K Buy
27,982
+3,477
+14% +$58.5K ﹤0.01% 1162
2018
Q3
$436K Buy
24,505
+6,900
+39% +$156K ﹤0.01% 1023
2018
Q2
$519K Buy
17,605
+800
+5% +$25.3K ﹤0.01% 1096
2018
Q1
$604K Buy
+16,805
New +$607K ﹤0.01% 1087

Other funds holding RDUS

Mackay Shields LLC's RDUS Position: Q3 2020 in Review

Mackay Shields LLC sold out of Radius Health, Inc. (RDUS) in Q3 2020, closing a stake of 72,688 shares — an estimated $990K sold.

Mackay Shields LLC first reported a position in RDUS in Q1 2018 and held it in 10 quarters. The position peaked at $1.57M in Q2 2019. 132 funds tracked by Wall St. Rank hold RDUS as of Q3 2020.

  • Mackay Shields LLC reported no remaining Radius Health, Inc. position as of Q3 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 72,688 Radius Health, Inc. shares in Q3 2020, an estimated $990K.
  • Mackay Shields LLC first reported a position in Radius Health, Inc. in Q1 2018 and held it in 10 quarters.
  • Mackay Shields LLC's Radius Health, Inc. position peaked at $1.57M in Q2 2019.
  • 132 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2020.

Based on Mackay Shields LLC's 13F filing for Q3 2020, filed 4 Nov 2020.